Sabra Health Care REIT (SBRA) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
17 Apr, 2026Executive summary
Achieved robust NOI growth in the SHOP portfolio and managed senior housing, with transition facilities and new investments expected to further boost performance in 2026.
Completed $450 million in 2025 investments, including four managed senior housing properties, and disposed of seven skilled nursing facilities for $51.0 million.
Focus on quality care, deep industry experience, and partnering with skilled operators positions the company for long-term value creation.
Corporate sustainability initiatives emphasize environmental stewardship, diversity, and governance, with notable workforce diversity achievements.
Declared a quarterly cash dividend of $0.30 per share, payable February 27, 2026.
Financial highlights
Q4 2025 normalized FFO per share was $0.36 and normalized AFFO per share was $0.38; net income per diluted share was $0.11.
Full-year 2025 net income was $155.6 million, up from $126.7 million in 2024.
Cash NOI from managed senior housing increased $5.5 million sequentially, with 12.6% year-over-year growth in Q4 2025.
Liquidity at year-end 2025 was $1.2 billion, including $71.5 million cash, $782.4 million revolver availability, and $322.7 million under forward sales agreements.
Weighted average debt maturity was 4.2 years, with no material maturities until 2028 and a cost of permanent debt at 3.92%.
Outlook and guidance
2026 guidance: Net income per share $0.60–$0.64, FFO $1.49–$1.53, AFFO $1.55–$1.59, implying ~5% year-over-year growth.
Low single-digit Cash NOI growth expected for the triple-net portfolio; low to mid-teens growth projected for same-store managed senior housing.
General and administrative expenses forecasted at $52 million, including $12 million stock-based compensation; cash interest expense at $103 million.
Management expects to exceed 2025’s investment total, with $240 million in awarded investments expected to close in early 2026.
Latest events from Sabra Health Care REIT
- Q2 2026 delivered strong investment and NOI growth, but a net loss from a major loan write-off.SBRA
Q2 2026 - Q1 2026 saw strong earnings, robust investments, and reaffirmed guidance for continued growth.SBRA
Q1 2026 - Proxy covers director elections, auditor ratification, and performance-based executive pay.SBRA
Proxy filing - Annual meeting seeks votes on directors, auditor, and executive pay, all board-recommended.SBRA
Proxy filing - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 2024 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 2024 - Q4 2024 saw strong managed senior housing growth, improved leverage, and a positive 2025 outlook.SBRA
Q4 2024